Wongbenjarat K. Central Nervous System Complications from Multiple Courses of the Monoclonal Antibbody Muromonab-CD3 (OKT3) Therapy: a Case Report. MNRHJ [internet]. 2025 Jan. 7 [cited 2025 Jul. 1];23(1):39-48. available from: https://he04.tci-thaijo.org/index.php/MNRHJ/article/view/2577